Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (8)

2021

  1. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    Scientific Reports, Vol. 11, Núm. 1

  2. The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial

    Cancers, Vol. 13, Núm. 10

2015

  1. CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

    Haematologica

2014

  1. Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

    Blood, Vol. 123, Núm. 20, pp. 3073-3079

2010

  1. Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis

    Neurologia, Vol. 25, Núm. 9, pp. 544-551

2007

  1. Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis

    Blood, Vol. 109, Núm. 10, pp. 4258-4263

1997

  1. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors

    Bone Marrow Transplantation, Vol. 20, Núm. 6, pp. 451-458

  2. Trasplante autólogo con esquema BEAM en linfoma

    Sangre, Vol. 42, Núm. SUPPL. 1, pp. 46-49